The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases.

Giovanni CioffiOmbretta ViapianaLuigi TarantiniGiovanni OrsoliniLuca IdolazziFederica OgnibeniAndrea DalbeniDavide GattiAngelo FassioGiovanni AdamiMaurizio RossiniAlessandro Giollo

Published in: Arthritis research & therapy (2021)

In light of our results, an increasingly accurate assessment of MetS would be required in patients with RMD as potential measure of clinical outcomes including the risk of cancer.

Keyphrases

papillary thyroid
metabolic syndrome
squamous cell
oxidative stress
type diabetes
lymph node metastasis
high resolution
insulin resistance
childhood cancer
adipose tissue
uric acid
cardiovascular risk factors